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In 1990, we developed the adult mouse model for studies on active immunity against shedding of the EDIM strain of murine rotavirus.
Low and inconsistent levels of EDIM shedding in some strains of adult mice, particularly those on C57BL/6 backgrounds, established the
need for an alternative murine rotavirus strain for these studies. Fortuitously, such a rotavirus strain was obtained from mice housed within
the conventional colony at Children’s Hospital. This strain, named EMcN, was clearly distinguishable from EDIM based on electropherotype.
Furthermore, sequence analyses of VP4 and VP7 genes of EMcN revealed non-identities in 5% of the amino acids of both proteins relative to
EDIM but established EMcN as another G3P[16] strain of murine rotavirus. Subgroup analysis showed EMcN belonged to SG1 while EDIM
was found to be non-SG1/SG2. Similarly, unlike EDIM, the EMcN strain was identified as serotype G3 based on neutralization by
hyperimmune antisera developed against prototype human and simian G3 rotavirus strains. Although EDIM produced more days of diarrhea
and was shed in greater quantities in neonatal BALB/c mice, EMcN was shed in much greater quantities in adult BALB/c mice. More
importantly, in contrast to the EDIM strain, EMcN was shown to be consistently shed in large quantities in adult C57BL/6 mice and ko mice
on this background. Therefore, it is recommended that the EMcN strain be used for future challenge studies with mice on this background.
D 2004 Elsevier Inc. All rights reserved.Keywords: Murine rotavirus; EDIM strain; C57BL/6 miceIntroduction
Studies on the mechanisms of protection against viral
diseases as well as the development of viral vaccines have
relied heavily on the use of animal model systems. Several
models for protection against rotavirus disease have also
been successfully developed and utilized with large animals
(Bishop et al., 1986; Bridger and Oldham, 1987; Hoshino et
al., 1988; Woode et al., 1987; Yuan et al., 1996, 2001) but
protection against rotavirus disease in mice has been limited
to passive immunization studies (Offit et al., 1986a,1986b).
This is because mice are susceptible to rotavirus disease
only during their first 2 weeks of life. This is too short of a
time in which to immunize, develop active immunity, and
reliably measure protection against disease after a subse-
quent rotavirus challenge. On the basis of rotavirus chal-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: dick.ward@cchmc.org (R.L. Ward).lenge studies in adult humans (Bernstein et al., 1991; Ward
et al., 1986, 1989, 1990a), where shedding of human
rotavirus in stool was the primary determinant of the
magnitude of the rotavirus infection, we developed the adult
mouse model for studies on active immunity (Ward et al.,
1990b). As with the human challenge studies, the primary
determinant for the severity of infection following challenge
with a murine rotavirus was the quantity of rotavirus shed in
stool determined with a sensitive enzyme-linked immuno-
sorbent assay (ELISA). Studies with this adult mouse model
have now been reported from multiple laboratories.
Until very recently, the only challenge virus used in our
laboratory with the adult mouse model was the murine
rotavirus strain EDIM. Other laboratories, however, have
utilized additional murine rotavirus strains with this chal-
lenge model (Burns et al., 1995; Dunn et al., 1994; Feng et
al., 1994). Most of our studies have been conducted with the
inbred BALB/c strain of mice where EDIM has been found
to reliably infect rotavirus-naı¨ve animals of all ages, result-
ing in the fecal shedding of large quantities of rotavirus
antigen that peaks at 3–6 days after challenge and is
resolved by 8 days (Choi et al., 1999; McNeal et al.,
Table 1
EDIM shedding in mice on a C57BL/6 background during separate
experiments with each mouse straina
Mouse strain Quantity of antigen shedb
C57BL/6 127 (F45)
1667 (F323)
C57BL/6 Nude 22 (F8)
2665 (F1262)
C57BL/6 AMt 28 (F12)
252 (F135)
C57BL/6 Rag-1 30 (F5)
291 (F88)
a Groups of 6 to 12 mice were infected by oral gavage with 1000 SD50 of wt
EDIM. Stool specimens were collected for 7 days after infection and the
quantity of rotavirus shed was determined by ELISA. The data shown
represent the findings of two separate experiments with each mouse strain.
All eight experiments shown were conducted independently on separate
dates.
b Mean quantity of rotavirus antigen shed (FSEM) during the 7 days after
EDIM challenge (ng mouse1 day1).
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detected after EDIM challenge of other mouse strains,
particularly C57BL/6 and genetically modified mice on a
C57BL/6 background, has been found to be less reliable and
sometimes undetectable (Choi et al., 2000). This has limited
the utility of the model and forced the abandonment of
certain experiments where strains with particular genetic
modifications were available only with mice on C57BL/6
backgrounds.
This limitation now appears to have been overcome with
the discovery of a new rotavirus strain that has been found
to reliably infect all strains of rotavirus-naı¨ve mice evaluat-
ed, and reproducibly stimulate the production of large
quantities of fecal rotavirus shedding during the week after
challenge. This manuscript describes this new strain and
compares its properties to those of the EDIM strain with
particular emphasis on their relative abilities to reliably
stimulate large quantities of rotavirus shedding after chal-
lenge of adult mice on C57BL/6 backgrounds.Results
Rotavirus antigen shedding is inconsistent after oral EDIM
challenge of adult mice on a C57BL/6 background
The adult mouse model for studies on active immunity
against rotavirus was developed using BALB/c mice chal-
lenged with the EDIM strain of murine rotavirus. Although
rotavirus antigen shedding during the week after EDIM
challenge of naı¨ve BALB/c mice was consistently high, this
consistency was lost when the EDIM challenge was per-
formed with other mouse strains. For example, EDIMFig. 1. Rotavirus antigen shedding in three separate experiments using
C57BL/6 mice. Groups of six to eight 6-week-old C57BL/6 mice were
inoculated with 1000 SD50 of wt EDIM by oral gavage. Two stool pellets
were then collected from each mouse daily for the following week into 1 ml
of Earle’s balanced salt solution (EBSS) and stored frozen at 20jC. These
specimens were then thawed, homogenized, and centrifuged to pellet
debris. Concentrations of rotavirus antigen were determined by ELISA and
expressed as the mean nanograms rotavirus antigen per mouse for each day.
Error bars represent standard errors of the mean.antigen shedding in a JHD (antibody deficient) mouse strain
on a mixed (AB-1  C57BL/6) background was so incon-
sistent that its use had to be discontinued after several
studies (McNeal et al., 1995). Likewise, attempts to perform
EDIM challenge studies with the parental C57BL/6 strain
resulted in huge variations in the quantities of rotavirus
antigen shed from one experiment to the next (Fig. 1).
Similar variations in rotavirus antigen shedding were also
found when genetically engineered (ko) mice on the
C57BL/6 background were challenged with EDIM (Table
1), and some mice in these studies produced no detectable
rotavirus shedding. Because of the urgent need to utilize ko
mice on the C57BL/6 background in mechanistic studies on
rotavirus immunity, it was critical to identify a rotavirus
strain that was consistently shed in large quantities after
challenge.
Isolation and electropherotype analysis of the EMcN strain
of murine rotavirus
In the year 2000, rotavirus antibody began to be detected
in the sera of mice housed in the conventional animal colony
at Children’s Hospital, Cincinnati. After several attempts,
the rotavirus responsible was detected by an ELISA in
stools obtained from a litter of 11-day-old BALB/c mice
with mild diarrhea housed in this facility. Polyacrylamide
gel electrophoresis of the viral RNA segments extracted
from these stool specimens revealed an electropherotype
that, although very similar, was distinct from that of EDIM
(Fig. 2). In fact, only 3 out of the 11 genome segments of
these two rotavirus strains (segments 3, 4, and 10) were
electrophoretically indistinguishable. The ‘‘shadow bands’’
in the EDIM lane are gel anomalies because they were not
seen in other PAGE profiles of genomic RNA extracted
from this virus. From these results, the new rotavirus strain,
which we named EMcN based on the method of identifica-
tion recommended by Burns et al. (1995), was clearly
Fig. 2. Electrophoretic patterns of genomic RNAs obtained from wt EDIM
and EMcN virus preparations as determined by SDS-PAGE.
Fig. 3. Phylogenetic analyses of the VP4 and VP7 proteins of EMcN and
other strains of murine rotavirus. Phylogenetic trees of VP4 (A) and VP7 (B)
proteins of EMcN and the other murine strains were constructed using a
GCG program (as described in Materials and methods). First, multiple
sequence alignments of VP4 and VP7 sequences of EMcN and the other
strains were performed by pairwise alignment. A matrix of the pairwise
distances was compiled using UPGMA (unweighted pair group method
using arithmetic averages). To construct the phylogenetic trees, sequences in
the matrix were combined progressively to form clusters based on the
numbers of differences, that is, number of substitutions among the amino
acid sequences. The line lengths in the trees denote the number of amino acid
substitutions present in the sequences and the scale represents one
substitution per 100 amino acid residues. The GenBank accession numbers
for the VP4 proteins are: EB, U08419; Eb-2, L18992; EDIM, AF029319;
EW, U08429; EC, U08421; EL, U08426; YR-1, D45215; EHP, U08424.
The GenBank accession numbers for the VP7 proteins are: EDIM,
AF039220; EW, U08430; EC, U08422; EL, U08427; EB, U08420; YR-1,
D45216; EHP, U08425.
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challenge studies at our center.
Comparative sequence analysis of capsid proteins of EDIM
and EMcN
Nucleotide sequence analyses of the outer capsid VP4
and VP7 protein genes of the EMcN strain were performed
and the deduced amino acid sequences of these genes were
compared with those of EDIM and other murine rotaviruses
present in GenBank. Phylogenetic analyses were then per-formed to compare the relatedness of the two proteins
between these rotavirus strains (Fig. 3). EMcN was clearly
distinct from all other strains. Interestingly, the degree of
amino acid identity among these murine rotavirus strains for
both the VP4 and VP7 proteins was very similar in almost
all instances, ranging from 91.9% to 97.2%. The only
exceptions were that EDIM and EW had nearly identical
sequences as expected because they were derived from the
same original isolate, the EL and EC strains were more
closely related to each other than to other strains (99.0% and
99.1% identities in amino acid sequences for their VP4 and
VP7 proteins, respectively), and the VP4 protein of the EHP
strain was distinctly different from that of the others (81.6–
83.1% identity) as already noted by Dunn et al. (1994).
Accordingly, murine rotaviruses have been classified within
two distinct VP4 or P genotypes represented by either EHP
(P20) or the other murine strains (P16) (Estes, 2001). The
EMcN strain belongs to the P16 genotype and, along with
all other murine strains, can be classified as G3 based on its
VP7 sequence (Nishikawa et al., 1989).
Table 3
Cross-neutralization analysis with hyperimmune sera to different G3
rotavirus strains or a G1 (Wa) rotavirus
Neutralizing antibody titers
Virus Anti-EDIM Anti-RRV Anti-SA11 Anti-P Anti-Wa
EMcN 1450 118,000 120,000 120,000 <100
EDIM 17,100a 19,100 <100 29,800 <100
RRV 2610 1,200,000 34,000 486,000 <100
SA11 1500 100,000 59,000 N.D.b N.D.
P <100 363,000 8500 366,000 790
Wa <100 <100 <100 <100 113,000
a Homologous virus titers are in boldface.
b Not determined.
Table 4
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The VP6 protein of rotavirus is the group antigen but
group A rotavirus strains have been separated into four
subgroups based on the recognition of their VP6 proteins by
subgrouping monoclonal antibodies (mAbs) (Gorziglia et
al., 1988; Greenberg et al., 1983a; Lopez et al., 1994; Tang
et al., 1997). The four subgroups are SG1, SG2, SG1/SG2,
and non-SG1/SG2. Using mAbs 255/60 [subgroup 1 (SG1)]
and 631/9 [subgroup 2 (SG2)], the EDIM strain was found
to be non-SG1/SG2, as already reported for the EW strain
(Tang et al., 1997), and the EMcN strain was found to
belong to SG1. Control SG1 (SA11) and SG2 (Wa) rotavi-
ruses were included in this analysis to establish the speci-
ficity of the mAbs. For both murine rotavirus strains, the
results were definitive based on cross-reactivity and back-
ground optical density values (results not shown). Sequence
analysis of the VP6 gene of EMcN revealed eight positions
of non-identity in comparison with the deduced amino acid
sequence of EDIM (Table 2). Therefore, the amino acid
change responsible for differences in the subgroup identities
of the two murine rotavirus strains could not be definitively
established by this analysis.
Serotyping of EMcN and EDIM
The serotypic relationships between EMcN and EDIM as
well as between these rotavirus strains and selected animal
or human rotavirus strains were determined based on cross-
neutralization with hyperimmune antiserum produced in
guinea pigs against the different virus strains. Neutralizing
antibody generated in sera after hyperimmunization of
animals with purified rotavirus particles has been found to
be almost solely directed against their VP7 proteins (Green-
berg et al., 1983b; Offit and Blavat, 1986; Ward et al., 1991)
and, therefore, these sera have been used to compare the
VP7 serotypes or G-types of rotaviruses based on cross-
neutralizing antibody titers. If the neutralizing antibody titer
found against one rotavirus strain is no more than 20-fold
less than the titer found against the strain used to immunize
the animals, the two rotaviruses are said to belong to the
same G-type. Using this definition, we previously reported
(Ward et al., 1992) that the EDIM strain displayed only a
weak one-way cross-neutralizing relationship with a limited
number of rotaviruses belonging to the G3 serotype even
though EDIM clearly belongs to G3 based on sequence
comparisons with VP7 genes of other rotavirus strains
M.M. McNeal et al. /4Table 2
Positions of non-identity in amino acid sequence of the VP6 proteins of the
EDIM and EMcN strains of rotavirus
Amino acid
101a 230 233 242 254 269 305 325
EDIM M E S D L V T R
EMcN V K K N W I A K
a Amino acid position.(Nishikawa et al., 1989). When the titers of these hyperim-
mune antisera were determined against cell culture-adapted
EMcN (passage 9), much closer relationships were found
with G3 simian (SA11 and RRV) and human (P) strains than
with EDIM (Table 3). Neither EDIM nor EMcN were
serotypically related to the human Wa (G1) strain used as
a control. Similarly, the G3 serotyping mAb 159 reacted
strongly (ELISA) with the G3 simian, human, and EMcN
rotavirus strains but only a very weak reaction was found
with EDIM and no reaction was found with Wa (results not
shown).
Shedding dose-50 (SD50) and diarrheal dose-50 (DD50) of
EDIM and EMcN in BALB/c mice
The major experimental use for murine rotaviruses is
for challenge studies in mice. We and others have used the
EDIM strain for this purpose in multiple studies in both
neonatal and adult BALB/c mice. During these studies, it
was noted that the dose of culture-adapted EDIM (EW
strain) required to infect 50% of adult mice (SD50) was
considerably greater than the dose required to cause
diarrhea in 50% of neonatal mice (DD50) (Burns et al.,
1995). A comparative evaluation was conducted with the
EDIM and EMcN strains in both neonatal and adult
BALB/c mice. Both rotavirus strains used for this chal-
lenge study were wild-type (wt) strains obtained after
passage only in neonatal mice and processed in an iden-
tical manner. Even so, the titer of the EDIM strain, as
measured in a cell culture focus assay, was >4 orders of
magnitude larger than that of EMcN (Table 4). TheseDetermination of the shedding and diarrheal dose 50 of EDIM and EMcN
in BALB/c micea
Virus Titer (ffu/ml) SD50 (ffu) DD50 (ffu)
EDIM 7.8  107 3.0  100 2.3  102
EMcN 3.0  103 4.0  104 2.9  103
a Viruses were obtained from the stools of infected neonatal mice and
partially purified before preparing and storing aliquots (80jC). The titer
of each preparation was measured by the fluorescent focus assay and serial
(10-fold) dilutions were used to infect adult and neonatal mice for
determination of SD50 and DD50, respectively.
Fig. 5. Quantification of rotavirus antigen in the intestinal contents of
neonatal mice following challenge with 1000 DD50 of either wt EDIM or wt
EMcN. Groups of 32 or 33 BALB/c mice were challenged by oral gavage at
5 days of age. On the day of challenge (day 0), and for the subsequent 15
days, two mice/group were sacrificed, their intestines were removed,
combined, weighed, and homogenized. The amounts of rotavirus antigen
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reflected in their DD50 values because <0.03 focus forming
unit (ffu) were required to induce diarrhea in neonatal mice
after inoculation with either rotavirus strain. Furthermore,
the DD50 of the EMcN strain was 8-fold less than that of
EDIM. The greater ability to infect BALB/c mice with
EMcN was even more apparent in adult mice where the
SD50 for EDIM was 4 orders of magnitude larger than for
EMcN.
Comparative patterns of diarrhea and rotavirus shedding
induced in neonatal or adult BALB/c mice challenged with
EDIM or EMcN
Because many fewer tissue culture infectious units (ffu)
of rotavirus were obtained from the stools of neonatal
BALB/c mice inoculated with EMcN than with EDIM
(Table 4), it was speculated that rotavirus diarrhea may
persist for less days in neonatal mice challenged with EMcN
and the quantities of rotavirus antigen detectable in the
intestines of these mice given EMcN may also be less. In
agreement with these suggestions, the numbers of days of
diarrhea were reduced by ca. 50% in neonatal mice chal-
lenged with EMcN relative to those given EDIM (Fig. 4),
and the quantities of rotavirus antigen found in the intestines
of these mice challenged with EMcN were also less (Fig. 5).
The relative quantities of rotavirus antigen produced after
infection of neonatal mice with the two rotavirus strains
were dramatically reversed in adult BALB/c mice (Fig. 6).
That is, EMcN was shed in much larger amounts (>10-fold)
than EDIM. This difference reflects the markedly reduced
SD50 for EMcN relative to EDIM found in adult BALB/c
mice (Table 4).Fig. 4. Percentages of neonatal mice with diarrhea after oral inoculation
with 1000 DD50 of either wt EDIM or wt EMcN. Groups (10 or 11 mice/
group) of BALB/c mice were administered virus by oral gavage 5 days after
birth and were evaluated daily for diarrhea following gentle palpation of
their abdomens. Differences between normal stools and diarrheal stools
were readily apparent and few neonatal mice excreted any stool under these
conditions unless they had diarrhea.Comparative shedding patterns of EDIM and EMcN in
adult mice on C57BL/6 backgrounds
As already mentioned, a major limitation of the EDIM
strain for challenge studies in adult mice is the inability to
obtain consistent shedding in mice on C57BL/6 back-
grounds. Because EMcN was found to be shed in much
larger amounts in adult BALB/c mice than EDIM, it was
possible that this virus strain would also be shed in large
quantities in adult mice on the C57BL/6 background, even
in mice strains that shed almost no detectable EDIM
antigen. Therefore, we compared the quantities of rotavirus
per gram of intestine were then determined by ELISA.Fig. 6. Quantification of rotavirus antigen shed in fecal matter of adult
BALB/c mice during the 7 days after oral challenge with 1000 SD50 of
either wt EDIM or wt EMcN. Groups of six (6-week-old) mice were
challenged with virus and two stool pellets were collected daily. These were
processed as described in Fig. 1 and measured for their concentrations of
rotavirus antigen by ELISA. These were expressed as the mean nanograms
rotavirus antigen shed per mouse each day F SEM.
Fig. 7. Quantification of rotavirus antigen shed in fecal matter of adult
C57BL/6 or C57BL/6 ko mice during the days after challenge with 1000
SD50 of either wt EDIM or wt EMcN. Groups of six to eight (6-week-old)
mice were challenged with virus and two stool pellets were collected daily
for 7–12 days. These specimens were analyzed for rotavirus antigen which
was quantified as described in Fig. 6.
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engineered ko mice strains on this background after
infection with EDIM or EMcN (Fig. 7). In every case,
rotavirus antigen shedding dramatically increased in
EMcN-infected mice relative to that found in mice inoc-
ulated with EDIM. Furthermore, the average amount of
EMcN antigen shed was consistently ca. 3 logs or greater
above the limit of detection (i.e., 5 ng/mouse) at the time
of maximal shedding.Discussion
Because of the many advantages of mice for studies on
active immunity, we developed the adult mouse model andreported our first results in 1990 (Ward et al., 1990b). This
model was initially developed using BALB/c mice that were
challenged with a murine rotavirus called EDIM. The term
EDIM is generic for murine rotaviruses as the agents of
‘‘epizootic diarrhea of infant mice’’. Several ‘‘EDIM’’
strains have been identified and have been assigned specific
names (Burns et al., 1995). The EDIM strain was originally
isolated by Kraft (1957) but when other investigators
obtained this virus from J. Wolf, they assigned it a more
specific name (i.e, EW; E for EDIM and W for Wolf)
(Greenberg et al., 1986; Wolf et al., 1981). Therefore, our
designation of EDIM and the EW designation of others refer
to an EDIM strain of the same origin. Although we have
found that relatively large and consistent amounts of EDIM
antigen shedding occur in adult BALB/c mice during the
week after challenge, this has not been true of all mouse
strains, particularly those on a C57BL/6 background. There-
fore, it was crucial that if these strains of mice were to be
used with the adult mouse model, we must utilize another
strain of murine rotavirus that did consistently produce large
amounts of rotavirus antigen after challenge. This report
concerns the fortuitous isolation and subsequent character-
ization of such a strain that we have named EMcN.
The isolation of the EMcN strain from 11-day-old mice
after their exposure to contaminated mice in the conven-
tional colony at the Children’s Hospital Animal Facility was
initially done to determine whether this strain differed from
the EDIM strain used in another part of this facility. Electro-
pherotyping of the RNA genome segments of this new
isolate clearly demonstrated it was not EDIM in that 8 out
its 11 segments were electrophoretically distinguishable.
Sequence analyses of the EMcN gene segments encoding
the VP4 and VP7 capsid proteins not only confirmed it was
distinct from EDIM but that it was also distinct from six
other strains of murine rotavirus, the VP4 and VP7 sequen-
ces of which had been submitted to GenBank. On the basis
of these analyses, EMcN is a G3[P16] strain like all the
other murine rotaviruses except EHP which has been
classified as G3[P20] (Estes, 2001). From these sequence
comparisons, it appears that both the VP4 and VP7 genes of
these rotavirus strains co-evolved such that they are approx-
imately equidistant from one another in almost all cases.
One exception is that the VP4 gene of EHP is unique and,
therefore, this virus strain probably arose through a reassort-
ment event since its VP7 gene appears to have co-evolved
with that of the other murine strains. Another exception is
that both proteins from the EC and EL strains differ from
one another by V1% while at least one of these two proteins
from all other paired comparisons (except EDIM and EW)
differ by z3.5%. This suggests that the EL and EC strains
separated more recently. The final exception is that the VP4
and VP7 proteins of EDIM and EW strains differed by only
three and one amino acid, respectively, an expected result
based on their common origin.
On the basis of the recognition by subgroup-specific
mAbs, EMcN belongs to subgroup 1 which is typical of
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strain belongs to non-SG1/SG2 (Tang et al., 1997) and the
same result was found with the EDIM strain. The VP6
protein, the group antigen for which the subgroups have
been identified, is highly conserved and the greatest
difference in amino acid sequence reported for this protein
between any two mammalian group A rotaviruses has been
approximately 13% (Gorziglia et al., 1988; Tang et al.,
1997). Therefore, it was not surprising that the VP6
proteins of EDIM and EMcN share 98.0% homology,
nearly 3% more than the homologies found in genes for
their two more rapidly evolving outer capsid neutralization
proteins. Most notable, one of the eight positions in the
VP6 proteins of these two rotavirus strains at which
differences were found was at amino acid 305 where the
change was from threonine (EDIM) to alanine (EMcN).
Tang et al. (1997) reported that a single mutation in the
VP6 gene of EW leading to a threonine to alanine change
at position 305 resulted in a switch in subgroup from non-
SG1/SG2 to SG1, the same difference as found between
EDIM and EMcN. However, because amino acids at
several distal sites within VP6 have been reported to
participate in recognition by SG1 mAb (Tang et al.,
1997), the importance of alanine at position 305 of the
VP6 protein of EMcN for this recognition cannot be
evaluated without further analyses.
On the basis of the sequence analyses of the VP7
protein gene, all murine rotaviruses evaluated are classified
as G3 including the EDIM and EMcN strains. Therefore, it
is somewhat surprising that hyperimmune antiserum gen-
erated in guinea pigs against EDIM, which has been
reported to be primarily directed against the VP7 protein
(Greenberg et al., 1983b; Offit and Blavat, 1986; Ward et
al., 1991), was shown to require at least 40-fold greater
concentrations to neutralize other G3 rotavirus strains
including the murine EB strain (Ward et al., 1992). Similar
results were found when antisera against EB and other G3
strains were used to neutralize EDIM. These results
suggested that the EDIM strain differed from the others
within regions of the VP7 protein containing its neutrali-
zation epitopes. When the neutralization titers of these
antisera were measured against EMcN, the results were
consistent with those found previously (Ward et al., 1992).
That is, EMcN was neutralized at serum concentrations
that were similar to those needed to neutralize all the
homologous G3 viruses except EDIM and appeared to be
most related to the SA11 strain. In spite of this, the VP7
proteins of EMcN and SA11 share only 89.6% identity
based on sequence information obtained from GenBank
while EMcN and EDIM VP7 proteins share 95.1% amino
acid identity. Therefore, it appears that similarities in the
neutralization epitopes within VP7 for different rotavirus
strains are not directly related to the overall identities of
their amino acid sequences.
Even though EMcN was readily distinguishable from
EDIM based on their respective genetic and immunologicalproperties, differences in the biological properties of the two
strains were even more apparent. Recoveries of infectious
virus from diarrheal stools of infected neonatal BALB/c
mice were >4 orders of magnitude larger for EDIM than for
EMcN obtained under similar conditions as measured in a
tissue culture (fluorescent focus) assay. Preparations of both
rotavirus strains, however, contained much more infectious
rotavirus than was detectable by the in vitro assay because
<0.03 ffu of either strain was required to cause diarrhea in
50% of inoculated neonatal mice. Furthermore, the EMcN
strain required 8-fold fewer ffu than EDIM. Differences in
the in vivo infectivity of the two rotavirus strains were much
more dramatic in adult BALB/c mice where the SD50 for
EMcN (4.0  104 ffu) was 10,000 times less than for
EDIM. These results are very similar to those reported by
Burns et al. (1995) when they compared the EW and EC
strains using these same assays. The EC strain in that study
behaved like the EMcN strain in the present study. This
greater similarity in biological properties of EMcN and EC
versus EMcN and EDIM is reflected in the somewhat
greater similarity of the VP4 and VP7 protein sequences
of EC and EMcN (see Fig. 3).
Possible explanations for the greatly reduced recovery of
ffu from neonatal mice inoculated with EMcN relative to
those administered EDIM are that diarrhea persists for a
shorter time after EMcN infection and the amount of
rotavirus produced in these mice, even during the diarrheal
period, was less after EMcN infection. Neonatal (4-day-old)
mice inoculated with EMcN experienced diarrhea for only 4
days while mice administered EDIM had diarrhea for up to
10 days. This is the age (2 weeks) when the window for
induction of rotavirus diarrhea in mice has been consistently
found to close (Ward et al., 1990b). Intestinal production of
rotavirus antigen was also greater in EDIM-infected neona-
tal mice but resolution of shedding occurred on the same
day, that is, 9 days after challenge. Therefore, shedding in
neonatal mice infected with EMcN extended several days
after the cessation of diarrhea but detectable shedding
stopped before diarrhea was resolved in mice infected with
EDIM. Taken together, the EDIM strain is clearly shed in
greater amounts in the diarrheal stools of neonatal mice.
However, this could not account of the >4 log difference in
recoverable yield of infectious virus detected in cell culture.
This suggests that factors in addition to the quantities of
rotavirus antigen shed, such as differences in the abilities of
EDIM and EMcN rotavirus particles to infect MA104 cells
in vitro, contributed to this finding.
The greater ability of EDIM to replicate relative to
EMcN after infection of neonatal BALB/c mice was dra-
matically reversed in adult BALB/c mice. In fact, every
adult BALB/c mouse inoculated with EMcN shed more than
any mouse given EDIM, and total shedding of EMcN
antigen was nearly 20-fold greater than EDIM. This differ-
ence was even more apparent when these viruses were used
to infect adult mouse strains on C57BL/6 backgrounds.
Some ko mice on this background shed no detectable EDIM
M.M. McNeal et al. / Virol8antigen while all strains tested consistently shed large
quantities of EMcN. This is potentially the most significant
feature of the EMcN strain. If these findings are consistently
found with other mouse strains, including some strains of
outbred mice in which EDIM has also been found to
produce inconsistent shedding, EMcN would be favored
over EDIM as the strain of choice for challenge studies in
adult mice.Materials and methods
Rotavirus strains
The EDIM strain of murine rotavirus was originally
isolated by Kraft (1957) and was assigned its name based
on its origin as the agent of ‘‘epizootic diarrhea of infant
mice’’. A stool preparation of this virus was obtained from
M. Collins, Microbiological Associates, Bethesda, MD, in
1980, and this virus was used as the initial inoculum. When
administered orally, this virus consistently induced diarrhea
in neonatal BALB/c mice that were <2 weeks of age and
consistently infected naı¨ve adult BALB/c mice of all ages,
resulting in the shedding of rotavirus antigen in their stools
as detected by an ELISA (Ward et al., 1990b, 1992). The wt
EDIM used in this study was obtained from the stools of
neonatal mice and was partially purified and concentrated as
previously described (Choi et al., 2002). Its titer in cell
culture was determined by a fluorescent focus assay with
MA104 cells and the titer of the preparation used in this
study was 7.8  107 ffu/ml. This virus was culture adapted
by nine passages in MA104 cells (Ward et al., 1990b) and
the culture-adapted preparation was plaque purified (3
times) before being passaged 4 additional times in these
same cells. This preparation was passage 16 of the culture-
adapted EDIM used in this study and its titer was 5.6  107
ffu/ml.
The EMcN strain of murine rotavirus was isolated from
the diarrheal stool of an 11-day-old BALB/c mouse that had
been exposed to infected mice within the conventional
mouse colony at Cincinnati Children’s Hospital Medical
Center. Once the presence of the virus was detected by an
ELISA, the clarified stool material was used to orally
inoculate other neonatal (4-day-old) BALB/c mice and the
virus in the combined stools was partially purified and
concentrated as previously described for the EDIM strain
(Choi et al., 2002). The titer of this wt EMcN preparation
was 3.0  103 ffu/ml as measured in MA104 cells. This
preparation was adapted to growth in cell culture by nine
passages in MA104 cells (Ward et al., 1990a,1990b) and
the titer of the culture-adapted preparation was 5.4  105
ffu/ml. The other rotaviruses used in this study were all
triply plaque purified preparations of prototype rotavirus
strains. These included the G3 simian rotavirus strains RRV
and SA11 as well as the human rotavirus strains P (G3) and
Wa (G1).Mouse strains
The strains of mice used for rotavirus infection were
either BALB/c (H-2d), C57BL/6 (H-2b), or genetically
modified (ko) mice on C57BL/6 backgrounds. These ko
mice included nude (thymus-less, T cell deficient), AMt (no
functional antibody) (Kitamura et al., 1991), and Rag-1
(lacking T and B cells). The BALB/c mice were obtained
from Harlan-Sprague-Dawley, Inc. (Indianapolis, IN) and all
mice on the C57BL/6 background were purchased from
Jackson Laboratories (Bar Harbor, ME). Female mice were
either purchased at 6 weeks of age and used for the adult
mouse studies or were purchased when pregnant and their
pups were used for neonatal inoculations. The mice were
housed in microisolation cages (four/cage) and all proce-
dures were conducted in accordance with a protocol ap-
proved by Cincinnati Children’s Hospital Research
Foundation Institutional Animal Care and Use Committee.
Electropherotyping of rotavirus genome segments
The double-stranded RNA genomes of wt EDIM and
EMcN were extracted and analyzed by SDS-PAGE as
described previously (Ward et al., 1988).
Purification of virus RNA
Extraction of rotavirus RNA from stools of mice shed-
ding rotavirus was carried out essentially as described (Choi
et al., 1997). Briefly, 10 volumes of TRIZOL (Invitrogen
Life Technologies, Carlsbad, CA) were added to the stool
and vortexed briefly. After 5 min, 0.2 volumes of chloro-
form were added and shaken vigorously for 15 s. The
mixture was spun (12,000  g, 15 min, 4jC) in a micro-
centrifuge to separate the aqueous and organic phases.
Isopropanol was then added to the aqueous phase and
mixed. The mixture was incubated at room temperature
for 10 min. Viral RNA was pelleted by centrifugation
(12,000  g, 10 min, 4jC) in a microcentrifuge, washed
with 75% ethanol, air dried, and resuspended in nuclease-
free H2O (Invitrogen Life Technologies).
RT/PCR
Double-stranded (ds) cDNAs of genes 4, 6, and 7 of
murine rotavirus strain EMcN were generated by reverse
transcription/polymerase chain reactions (RT/PCR) using
the ThermoScript RT-PCR System kit (Invitrogen Life
Technologies) and Vent DNA polymerase (New England
BioLabs, Beverly, MA). Briefly, RT was performed using 1
Ag of purified ds genomic RNA in 25 Al of distilled water
containing 200 nM of a forward primer (gene 4: 5V-GGC
TAT AAA ATG GCT TCA CTC-3V, gene 6: 5V-GGC TTT
TAA ACG AAG TCT TC-3V, and gene 7: 5V-GGC TTT
AAA AGA GAG AAT TTC CGT-3V) and a reverse primer
(gene 4: 5V-GGT CAC ATC CTC TAG ACA CTG-3V, gene
ogy 320 (2004) 1–11
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gene 7: 5V-GGT CAC ATC ATA CAG CTG TAA CTT-3V)
along with an RNase inhibitor (20 units of RnaseOut,
Invitrogen Life Technologies). The primers used were based
on the terminal sequences of the 5V and 3V non-coding
regions (NCR) of genes 4, 6, and 7 of murine rotavirus
strain EDIM. Due to the short 5V NTR of gene 4, the 18-mer
forward primer contains two EDIM-derived codons GCT
TCA (alanine and serine, respectively) that immediately
follow the start codon (ATG). These two amino acids are
conserved among all murine VP4 proteins. The reaction
mixture was denatured (3 min, 94jC) and the primers were
allowed to rapidly anneal to viral RNA by cooling the
suspension on ice. Two volumes of the ThermoScript
Reaction Mix were added to the denatured RNA. Reverse
transcription was carried out at 50jC for 60 min. The RT
reaction product (1 Al) was used for PCR with Vent DNA
polymerase (New England BioLabs) in a 25 Al volume.
Thirty cycles of PCR were carried out followed by a final
treatment at 72jC for 15 min. The PCR cycles for ampli-
fying gene 4 were: 1 min, 94jC; 2 min, 57jC; and 3 min,
72jC. For VP6 and VP7, the extension steps were 2.5 min,
72jC and 2 min, 70jC, respectively. The nucleotide sequen-
ces of the EMcN VP4, 6, and 7 genes were determined
using ds cDNA generated by RT/PCR as templates. Se-
quencing was performed by Cleveland Genomics (Cleve-
land, OH) using an ABI DNA Sequencer (Applied
Biosystems, Foster City, CA). The primer pair used for
generating dsDNAwas also used to sequence the initial 500
nucleotides from the ends of the positive and the negative
cDNA strands. New primer pairs were designed using the
sequence generated until both cDNA strands were com-
pletely sequenced. The gene sequence was determined twice
using PCR products generated in separate reactions using
both strands as templates. The GenBank accession numbers
are as follows: EMcN VP4, AY267006; EMcN VP6,
AY267007; EMcN VP7, AY267008.
Phylogenetics analyses
Phylogenetic trees of VP4 and VP7 proteins of EMcN
and other murine strains were constructed using GrowTrees,
a GCG program (Accelrys, San Diego, CA). First, multiple
sequence alignment of VP4 or VP7 sequences of EMcN and
other murine strains (obtained from GenBank) was per-
formed using progressive pairwise alignments. The program
Distances then created a matrix of pairwise distances using
the UPGMA method, that is, unweighted pair group method
using arithmetic averages (Sneath and Sokal, 1973). The
UPGMA method assumes that the expected rate of gene
substitution is constant for VP4 and VP7, and the distances
are measured as amino acid substitutions. To construct a
phylogenetic tree, the two sequences that have the smallest
distance in the distance matrix are combined to form a
cluster. That cluster replaces the original sequence pair as a
single entry in the distance matrix (reducing the dimensionof the matrix by 1), and distances between the cluster and
the other entries are calculated. The entries in the new
matrix that have the smallest distance are combined to form
a new cluster, and the process continues until only a single
cluster remains.
Subgroup analyses
Subgroup was determined by use of mAbs 225/60
(Subgroup I) and 631/9 (Subgroup II) obtained from H.B.
Greenberg , Stanford University School of Medicine, Stan-
ford, CA. In brief, ELISA plates (Costar-Corning Inc.,
Corning, NY) were coated overnight at 4jC with serum
from rabbits hyperimmunized with purified double-layered
SA11 rotavirus particles for positive wells or with normal
rabbit sera for negative wells. After washing the plates with
wash buffer (PBS + 0.05% Tween 20; Sigma, St Louis,
MO), viral samples, stool suspensions, or tissue culture
lysates were treated with 5 mM EDTA for 1 h at room
temperature (RT) and then added to duplicate positive and
negative wells. The plates were incubated (37jC, 1 h) and
washed. Subgroup-specific mAbs were then added to wells
containing each of the viruses being tested and incubated
(RT, 1 h). After washing, biotinylated goat anti-mouse IgG
(Sigma) was added (RT, 30 min), followed by washing and
addition of avidin–biotin–horseradish peroxidase (Vectas-
tain ABC Kit, Vector Laboratories, Burlingame, CA). Wells
were developed by adding o-phenylenediamine (OPD; Sig-
ma) and stopped after 15 min with 1.0 M H2SO4. A sample
was considered positive for a subgroup if the OD value of
the positively coated well was >2 times that of the nega-
tively coated well.
Determination of neutralizing antibody titers using
hyperimmune guinea pig antisera
Plaque-purified isolates of EDIM, G3 simian rotavirus
strains RRV and SA11, and human rotaviruses P (G3) and
Wa (G1) were grown in MA104 cells, then purified by CsCl
gradient centrifugation and subsequently inoculated (3
times) intraperitoneally into guinea pigs together with ad-
juvant as previously described (Ward and Knowlton, 1985).
The neutralizing antibody titers of the hyperimmune sera
collected from these animals against one another and against
the EMcN strain were determined using an EIA detection
procedure described in detail elsewhere (Knowlton et al.,
1991).
Experimental infection of neonatal or adult mice with EDIM
or EMcN
To determine the SD50 in adult mice and the DD50 in
neonatal mice, groups of adult and 5-day-old litters of
BALB/c mice were infected by oral gavage using 10-fold
serial dilutions of either wt EDIM or wt EMcN in volumes
of 100 Al. Stools were collected from the adult mice daily
M.M. McNeal et al. / Virology 320 (2004) 1–1110for 7 days after infection and the quantity of viral antigen
shed was determined by ELISA as described previously
(McNeal et al., 1999). The neonatal mice were examined
daily for evidence of diarrhea after gentle palpation of their
abdomens and percentage ill was determined. The SD50 and
the DD50 were determined by the method of Reed and
Muench (1938). In addition, the quantity of virus shed in 5-
day-old neonates infected with 1000 DD50 of either wt
EDIM or wt EMcN was determined by sacrificing two pups
on each day after infection, removing, weighing, and
homogenizing the intestine, and then quantifying the
amount of rotavirus antigen present per gram of intestine
by ELISA. Quantification of rotavirus shedding of the two
viruses in adult mice was determined after inoculating
groups of mice with 1000 SD50 of each virus, collecting
stools from each mouse for 7 days and measuring the
amount of antigen in the stools by ELISA (McNeal et al.,
1999). Adult C57BL/6 mice and knockout mice on that
background were infected with 1000 SD50 of either wt
EDIM or wt EMcN by oral gavage, and the amounts of
rotavirus antigen shed were determined by ELISA using the
same procedures.References
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